| Net profit of Kilitch Drugs (India) rose 0.84% to Rs 3.59 crore in the quarter ended March 2024 as against Rs 3.56 crore during the previous quarter ended March 2023. Sales declined 1.45% to Rs 44.82 crore in the quarter ended March 2024 as against Rs 45.48 crore during the previous quarter ended March 2023.
For the full year,net profit rose 39.71% to Rs 14.60 crore in the year ended March 2024 as against Rs 10.45 crore during the previous year ended March 2023. Sales rose 10.58% to Rs 154.37 crore in the year ended March 2024 as against Rs 139.60 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended | | | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 44.82 | 45.48 | -1 | 154.37 | 139.60 | 11 |
| OPM % | 15.80 | 13.65 | - | 15.64 | 12.58 | - |
| PBDT | 6.23 | 6.03 | 3 | 22.70 | 15.56 | 46 |
| PBT | 5.30 | 5.11 | 4 | 19.35 | 12.01 | 61 |
| NP | 3.59 | 3.56 | 1 | 14.60 | 10.45 | 40 |
|